nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—Headache—Tamoxifen—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Estazolam—Rash—Erlotinib—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Estazolam—Dermatitis—Erlotinib—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Estazolam—Dyspepsia—Irinotecan—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Estazolam—Headache—Erlotinib—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Estazolam—Pain in extremity—Doxorubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Estazolam—Diplopia—Doxorubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Estazolam—Paraesthesia—Gemcitabine—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Estazolam—Chills—Docetaxel—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Estazolam—Asthenia—Sunitinib—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Estazolam—Dry skin—Epirubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Estazolam—Decreased appetite—Irinotecan—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Estazolam—Arrhythmia—Docetaxel—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Estazolam—Dyspnoea—Gemcitabine—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Estazolam—Somnolence—Gemcitabine—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Estazolam—Affect lability—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Estazolam—Paraesthesia—Fluorouracil—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Estazolam—Pruritus—Sunitinib—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Estazolam—Pain—Irinotecan—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Constipation—Irinotecan—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Dyspnoea—Fluorouracil—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Somnolence—Fluorouracil—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Estazolam—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Estazolam—Malnutrition—Docetaxel—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Estazolam—Decreased appetite—Gemcitabine—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Estazolam—Dyspepsia—Fluorouracil—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Estazolam—Nausea—Tamoxifen—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Estazolam—Gastritis—Epirubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Estazolam—Pain—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Estazolam—Constipation—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Estazolam—Nausea—Erlotinib—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Estazolam—Decreased appetite—Fluorouracil—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Estazolam—Mood swings—Doxorubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Estazolam—Ataxia—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Estazolam—Feeling abnormal—Irinotecan—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Estazolam—Asthma—Epirubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Estazolam—Back pain—Docetaxel—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Estazolam—Pain—Fluorouracil—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Estazolam—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Estazolam—Muscle spasms—Docetaxel—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Estazolam—Dry skin—Doxorubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Estazolam—Dizziness—Sunitinib—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Estazolam—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Estazolam—Abdominal pain—Irinotecan—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Estazolam—Body temperature increased—Irinotecan—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Estazolam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Estazolam—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Estazolam—Gastritis—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Estazolam—Vomiting—Sunitinib—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Estazolam—Body temperature increased—Gemcitabine—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Estazolam—Rash—Sunitinib—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Estazolam—Dermatitis—Sunitinib—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Estazolam—Urticaria—Fluorouracil—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Estazolam—Headache—Sunitinib—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Estazolam—Syncope—Docetaxel—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Estazolam—Asthma—Doxorubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Estazolam—Leukopenia—Docetaxel—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Estazolam—Pollakiuria—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Estazolam—Body temperature increased—Fluorouracil—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Estazolam—Palpitations—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Estazolam—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Estazolam—Weight increased—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Estazolam—Loss of consciousness—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Estazolam—Weight decreased—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Estazolam—Cough—Docetaxel—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Estazolam—Hypersensitivity—Irinotecan—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Estazolam—Convulsion—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Estazolam—Arthralgia—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Estazolam—Chest pain—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Estazolam—Myalgia—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Estazolam—Nausea—Sunitinib—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Estazolam—Asthenia—Irinotecan—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Estazolam—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Estazolam—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Estazolam—Dry mouth—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Estazolam—Sweating—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Estazolam—Pollakiuria—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Estazolam—Asthenia—Gemcitabine—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Estazolam—Haematuria—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Estazolam—Confusional state—Docetaxel—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Estazolam—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Estazolam—Oedema—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Estazolam—Weight increased—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Estazolam—Epistaxis—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Estazolam—Pruritus—Gemcitabine—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Estazolam—Weight decreased—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Estazolam—Sinusitis—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Estazolam—Agranulocytosis—Epirubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Estazolam—Shock—Docetaxel—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Estazolam—Pruritus—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Estazolam—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Estazolam—Dizziness—Irinotecan—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Estazolam—Rhinitis—Epirubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Estazolam—Pharyngitis—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Estazolam—Sweating—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Estazolam—Haematuria—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Estazolam—Epistaxis—Doxorubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Estazolam—Vomiting—Irinotecan—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Estazolam—Sinusitis—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Estazolam—Dizziness—Fluorouracil—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Estazolam—Visual impairment—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Estazolam—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Estazolam—Rash—Irinotecan—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Estazolam—Dermatitis—Irinotecan—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Estazolam—Headache—Irinotecan—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Estazolam—Paraesthesia—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Estazolam—Erythema multiforme—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Estazolam—Vomiting—Gemcitabine—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Estazolam—Dyspnoea—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Estazolam—Somnolence—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Rash—Gemcitabine—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Dermatitis—Gemcitabine—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Tinnitus—Epirubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Headache—Gemcitabine—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Flushing—Epirubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Vomiting—Fluorouracil—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Estazolam—Dyspepsia—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Estazolam—Rash—Fluorouracil—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Estazolam—Dermatitis—Fluorouracil—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Estazolam—Pharyngitis—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Estazolam—Decreased appetite—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Estazolam—Headache—Fluorouracil—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Estazolam—Nausea—Irinotecan—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Estazolam—Constipation—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Estazolam—Pain—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Estazolam—Chills—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Estazolam—Arrhythmia—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Estazolam—Nausea—Gemcitabine—pancreatic cancer	0.001	0.001	CcSEcCtD
Estazolam—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000995	0.000995	CcSEcCtD
Estazolam—Malnutrition—Epirubicin—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Estazolam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000987	0.000987	CcSEcCtD
Estazolam—Nausea—Fluorouracil—pancreatic cancer	0.000986	0.000986	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—pancreatic cancer	0.000981	0.000981	CcSEcCtD
Estazolam—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00098	0.00098	CcSEcCtD
Estazolam—Flushing—Doxorubicin—pancreatic cancer	0.000977	0.000977	CcSEcCtD
Estazolam—Flatulence—Epirubicin—pancreatic cancer	0.000976	0.000976	CcSEcCtD
Estazolam—Tension—Epirubicin—pancreatic cancer	0.000971	0.000971	CcSEcCtD
Estazolam—Nervousness—Epirubicin—pancreatic cancer	0.000962	0.000962	CcSEcCtD
Estazolam—Back pain—Epirubicin—pancreatic cancer	0.000958	0.000958	CcSEcCtD
Estazolam—Muscle spasms—Epirubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Estazolam—Abdominal pain—Docetaxel—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Estazolam—Body temperature increased—Docetaxel—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Estazolam—Chills—Doxorubicin—pancreatic cancer	0.000944	0.000944	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—pancreatic cancer	0.00094	0.00094	CcSEcCtD
Estazolam—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000919	0.000919	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Estazolam—Agitation—Epirubicin—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—pancreatic cancer	0.000903	0.000903	CcSEcCtD
Estazolam—Tension—Doxorubicin—pancreatic cancer	0.000899	0.000899	CcSEcCtD
Estazolam—Malaise—Epirubicin—pancreatic cancer	0.000893	0.000893	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—pancreatic cancer	0.00089	0.00089	CcSEcCtD
Estazolam—Syncope—Epirubicin—pancreatic cancer	0.000888	0.000888	CcSEcCtD
Estazolam—Leukopenia—Epirubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Estazolam—Back pain—Doxorubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Estazolam—Hypersensitivity—Docetaxel—pancreatic cancer	0.000883	0.000883	CcSEcCtD
Estazolam—Muscle spasms—Doxorubicin—pancreatic cancer	0.000881	0.000881	CcSEcCtD
Estazolam—Palpitations—Epirubicin—pancreatic cancer	0.000875	0.000875	CcSEcCtD
Estazolam—Loss of consciousness—Epirubicin—pancreatic cancer	0.00087	0.00087	CcSEcCtD
Estazolam—Cough—Epirubicin—pancreatic cancer	0.000864	0.000864	CcSEcCtD
Estazolam—Asthenia—Docetaxel—pancreatic cancer	0.000859	0.000859	CcSEcCtD
Estazolam—Convulsion—Epirubicin—pancreatic cancer	0.000858	0.000858	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Estazolam—Pruritus—Docetaxel—pancreatic cancer	0.000848	0.000848	CcSEcCtD
Estazolam—Arthralgia—Epirubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Estazolam—Chest pain—Epirubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Estazolam—Myalgia—Epirubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Estazolam—Agitation—Doxorubicin—pancreatic cancer	0.000842	0.000842	CcSEcCtD
Estazolam—Anxiety—Epirubicin—pancreatic cancer	0.00084	0.00084	CcSEcCtD
Estazolam—Discomfort—Epirubicin—pancreatic cancer	0.000833	0.000833	CcSEcCtD
Estazolam—Malaise—Doxorubicin—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Estazolam—Dry mouth—Epirubicin—pancreatic cancer	0.000824	0.000824	CcSEcCtD
Estazolam—Syncope—Doxorubicin—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Estazolam—Leukopenia—Doxorubicin—pancreatic cancer	0.00082	0.00082	CcSEcCtD
Estazolam—Confusional state—Epirubicin—pancreatic cancer	0.000815	0.000815	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—pancreatic cancer	0.00081	0.00081	CcSEcCtD
Estazolam—Oedema—Epirubicin—pancreatic cancer	0.000808	0.000808	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Estazolam—Cough—Doxorubicin—pancreatic cancer	0.000799	0.000799	CcSEcCtD
Estazolam—Shock—Epirubicin—pancreatic cancer	0.000795	0.000795	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—pancreatic cancer	0.000794	0.000794	CcSEcCtD
Estazolam—Dizziness—Docetaxel—pancreatic cancer	0.000792	0.000792	CcSEcCtD
Estazolam—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000781	0.000781	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—pancreatic cancer	0.000777	0.000777	CcSEcCtD
Estazolam—Discomfort—Doxorubicin—pancreatic cancer	0.000771	0.000771	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—pancreatic cancer	0.000763	0.000763	CcSEcCtD
Estazolam—Vomiting—Docetaxel—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Estazolam—Rash—Docetaxel—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Estazolam—Dermatitis—Docetaxel—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Estazolam—Confusional state—Doxorubicin—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Estazolam—Headache—Docetaxel—pancreatic cancer	0.00075	0.00075	CcSEcCtD
Estazolam—Oedema—Doxorubicin—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Estazolam—Shock—Doxorubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Estazolam—Paraesthesia—Epirubicin—pancreatic cancer	0.000726	0.000726	CcSEcCtD
Estazolam—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Estazolam—Dyspnoea—Epirubicin—pancreatic cancer	0.00072	0.00072	CcSEcCtD
Estazolam—Somnolence—Epirubicin—pancreatic cancer	0.000718	0.000718	CcSEcCtD
Estazolam—Nausea—Docetaxel—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Estazolam—Dyspepsia—Epirubicin—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Estazolam—Decreased appetite—Epirubicin—pancreatic cancer	0.000702	0.000702	CcSEcCtD
Estazolam—Pain—Epirubicin—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Estazolam—Constipation—Epirubicin—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Estazolam—Paraesthesia—Doxorubicin—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Estazolam—Dyspnoea—Doxorubicin—pancreatic cancer	0.000667	0.000667	CcSEcCtD
Estazolam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—pancreatic cancer	0.000665	0.000665	CcSEcCtD
Estazolam—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000661	0.000661	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—pancreatic cancer	0.000658	0.000658	CcSEcCtD
Estazolam—Decreased appetite—Doxorubicin—pancreatic cancer	0.00065	0.00065	CcSEcCtD
Estazolam—Urticaria—Epirubicin—pancreatic cancer	0.000642	0.000642	CcSEcCtD
Estazolam—Pain—Doxorubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Estazolam—Constipation—Doxorubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Estazolam—Abdominal pain—Epirubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Estazolam—Body temperature increased—Epirubicin—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Estazolam—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000616	0.000616	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000611	0.000611	CcSEcCtD
Estazolam—Hypersensitivity—Epirubicin—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Estazolam—Urticaria—Doxorubicin—pancreatic cancer	0.000594	0.000594	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Estazolam—Asthenia—Epirubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Estazolam—Pruritus—Epirubicin—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Estazolam—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Estazolam—Asthenia—Doxorubicin—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Estazolam—Dizziness—Epirubicin—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Estazolam—Pruritus—Doxorubicin—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Estazolam—Vomiting—Epirubicin—pancreatic cancer	0.000514	0.000514	CcSEcCtD
Estazolam—Rash—Epirubicin—pancreatic cancer	0.000509	0.000509	CcSEcCtD
Estazolam—Dermatitis—Epirubicin—pancreatic cancer	0.000509	0.000509	CcSEcCtD
Estazolam—Headache—Epirubicin—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Estazolam—Dizziness—Doxorubicin—pancreatic cancer	0.000494	0.000494	CcSEcCtD
Estazolam—Nausea—Epirubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—pancreatic cancer	0.000475	0.000475	CcSEcCtD
Estazolam—Rash—Doxorubicin—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Estazolam—Headache—Doxorubicin—pancreatic cancer	0.000468	0.000468	CcSEcCtD
Estazolam—Nausea—Doxorubicin—pancreatic cancer	0.000444	0.000444	CcSEcCtD
